Modeling new therapies for infantile spasms

Area of Science:

• Neurology
• Pediatric Neurology
• Epileptology

Background:

• Infantile spasms (IS) are the hallmark seizure type of West syndrome, often associated with poor prognosis and cognitive impairment.
• Current treatments like ACTH, steroids, and vigabatrin have limitations due to toxicity and variable efficacy.
• The urgent need for novel therapies has driven the development of various rodent models for IS.

Purpose of the Study:

• To review clinical experiences in treating infantile spasms.
• To summarize the characteristics of newly developed animal models for infantile spasms.
• To discuss the utility of these models in preclinical research for new IS therapies.

Main Methods:

• Review of clinical treatment strategies for infantile spasms.
• Analysis of existing literature on rodent models of infantile spasms (acute, chronic, cryptogenic, symptomatic).
• Evaluation of the relevance of these models for preclinical drug development.

Main Results:

• Clinical treatments for IS include hormonal therapies and vigabatrin, but with significant side effects.
• Rodent models vary in etiology and induction methods, offering diverse platforms for research.
• These models are instrumental in understanding IS pathophysiology and testing novel therapeutic agents.

Conclusions:

• Effective treatment of infantile spasms is critical to prevent long-term neurological deficits.
• Rodent models provide valuable tools for advancing the preclinical development of innovative IS therapies.
• Further research utilizing these models is essential for improving outcomes in West syndrome.